参考文献/References:
[1] Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults?[J]. J Clin Endocrinol Metab,2013,98(10):E1610-E1619. DOI: 10.1210/jc.2013-2038.
[2] Grant RW, Dixit VD. Adipose tissue as an immunological organ[J].Obesity(Silver Spring), 2015,23(3):512-518. DOI: 10.1002/oby.21003.
[3] Seijkens T, Kusters P, Chatzigeorgiou A,et al. Immune cell crosstalk in obesity: a key role for costimulation [J]. Diabetes,2014,63(12):3982-3991. DOI: 10.2337/db14-0272.
[4] Eguchi J, Kong X, Tenta M,et al. Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization[J].Diabetes,2013,62(10):3394-3403. DOI: 10.2337/db12-1327.
[5] Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines[J].Immunity,2014,41(1):14-20. DOI: 10.1016/j.immuni.2014.06.008.
[6] Patsouris D, Li PP, Thapar D, et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals[J].Cell Metab,2008,8(4):301-309. DOI: 10.1016/j.cmet.2008.08.015.
[7] Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance[J].Proc Natl Acad Sci U S A,2011,108(37):15324-15329. DOI: 10.1073/pnas.1100255108.
[8] Xu L, Kitade H, Ni Y, et al. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease[J].Biomolecules,2015,5(3):1563-1579. DOI: 10.3390/biom5031563.
[9] Bourlier V, Bouloumie A. Role of macrophage tissue infiltration in obesity and insulin resistance[J].Diabetes Metab,2009,35(4):251-260. DOI: 10.1016/j.diabet.2009.05.001.
[10] Féral CC, Neels JG, Kummer C,et al. Blockade of alpha4 integrin signaling ameliorates the metabolic consequences of high-fat diet-induced obesity[J].Diabetes,2008,57(7):1842-1851. DOI: 10.2337/db07-1751.
[11] Kawano Y, Nakae J, Watanabe N,et al. Loss of Pdk1-Foxo1 signaling in myeloid cells predisposes to adipose tissue inflammation and insulin resistance[J].Diabetes,2012,61(8):1935-1948. DOI: 10.2337/db11-0770.
[12] Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization[J].J Clin Invest,2007,117(1):175-184.
[13] Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance[J].Cell Metab,2008,7(6):496-507. DOI: 10.1016/j.cmet.2008.04.003.
[14] Yang Y, Qin J, Lan L, et al. M-CSF cooperating with NFκB induces macrophage transformation from M1 to M2 by upregulating c-Jun[J]. Cancer Biol Ther,2014,15(1):99-107. DOI: 10.4161/cbt.26718.
[15] Spence S, Fitzsimons A, Boyd CR, et al. Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization[J]. Immunity,2013, 39(1): 196-197.DOI: 10.1016/j.immuni.2012.09.013.
[16] Mandal P, Pratt BT, Barnes M,et al. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin[J].J Biol Chem,2011,286(15):13460-13469. DOI: 10.1074/jbc.M110.204644.
[17] Wu D, Molofsky AB, Liang HE,et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis[J].Science,2011,332(6026):243-247. DOI: 10.1126/science.1201475.
[18] Liu J, Divoux A, Sun J,et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice[J].Nat Med,2009,15(8):940-945. DOI: 10.1038/nm.1994.
[19] Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens[J].Nat Rev Immunol,2010,10(6):440-452. DOI: 10.1038/nri2782.
[20] Tsuruda T, Kato J, Hatakeyama K,et al. Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm[J].Circ Res,2008,102(11):1368-1377.DOI: 10.1161/CIRCRESAHA.108.173682.
[21] Nijhuis J, Rensen SS, Slaats Y,et al. Neutrophil activation in morbid obesity, chronic activation of acute inflammation[J]. Obesity(Silver Spring),2009,17(11):2014-2018. DOI: 10.1038/oby.2009.113.
[22] Talukdar S, Oh da Y, Bandyopadhyay G,et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase[J].Nat Med,2012,18(9):1407-1412.
[23] Stefanovic-Racic M, Yang X, Turner MS,et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver[J].Diabetes,2012,61(9):2330-2339. DOI: 10.2337/db11-1523.
[24] Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients[J].Diabetes,2012,61(9):2238-2247. DOI: 10.2337/db11-1274.
[25] Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease[J].Nat Rev Immunol,2013,13(1):9-22. DOI: 10.1038/nri3341.
[26] Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI,et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity[J].Proc Natl Acad Sci U S A,2010,107(52):22617-22622. DOI: 10.1073/pnas.1009152108.
[27] Wu D, Molofsky AB, Liang HE,et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis[J].Science,2011,332(6026):243-247. DOI: 10.1126/science.1201475.
[28] Molofsky AB, Nussbaum JC, Liang HE, et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages[J].J Exp Med,2013,210(3):535-549. DOI: 10.1084/jem.20121964.
[29] Ji Y, Sun S, Xia S, et al. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4[J].J Biol Chem,2012,287(29):24378-24386. DOI: 10.1074/jbc.M112.371807.
[30] Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance[J].Biochim Biophys Acta,2014,1842(3):446-462. DOI: 10.1016/j.bbadis.2013.05.017.
[31] Lynch L, Nowak M, Varghese B,et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production[J]. Immunity,2012,37(3):574-587. DOI: 10.1016/j.immuni.2012.06.016.
[32] Huh JY, Kim JI, Park YJ, et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells[J].Mol Cell Biol,2013,33(2):328-339. DOI: 10.1128/MCB.00552-12.
[33] Lynch L, Michelet X, Zhang S, et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg)cells and macrophages in adipose tissue[J]. Nat Immunol,2015,16(1):85-95. DOI: 10.1038/ni.3047.
相似文献/References:
[1]编辑部.网上快讯[J].国际内分泌代谢杂志,2007,(04):238.
[2]张晓燕,陈莉明.儿童非酒精性脂肪性肝病研究进展[J].国际内分泌代谢杂志,2007,(04):289.
[3]李娜娜 任寿安.慢性间歇低氧对大鼠肝细胞IRS-2、FoxO1表达的影响[J].国际内分泌代谢杂志,2015,(01):1.[doi:10.3760/cma.j.issn.1673-4157.2015.01.001]
Li Nana,Ren Shouan.Effects of chronic intermittent hypoxia on IRS-2 and FoxO1 expression in rat heptocytes[J].International Journal of Endocrinology and Metabolism,2015,(04):1.[doi:10.3760/cma.j.issn.1673-4157.2015.01.001]
[4]任国梅,任寿安.间歇低氧对大鼠肝脏GSK-3及mTOR表达的影响[J].国际内分泌代谢杂志,2015,(02):77.[doi:10.3760/cma.j.issn.1673-4157.2015.02.002]
Ren Guomei,Ren Shouan..Effects of intermittent hypoxia on the expression of GSK-3 and mTOR in rat liver[J].International Journal of Endocrinology and Metabolism,2015,(04):77.[doi:10.3760/cma.j.issn.1673-4157.2015.02.002]
[5]刘美娟,朱惠娟,龚凤英.Glypican-，4与肥胖及胰岛素抵抗[J].国际内分泌代谢杂志,2015,(03):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
Liu Meijuan,Zhu Huijuan,Gong Fengying..Glypican-4 and obesity，insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(04):183.[doi:10.3760/cma.j.issn.1673-4157.2015.03.011]
[6]刘乐,于会宁,郭晓坤,等.OGTT 0.5 h血糖切点值在诊断糖尿病及糖尿病前期中的临床意义[J].国际内分泌代谢杂志,2015,(04):217.[doi:10.3760/cma.j.issn.1673-4157.2015.04.001]
Liu Le*,Yu Huining,Guo Xiaokun,et al.Clinical value of 0.5 h-plasma glucose and its cutoff value during OGTT in diagnosing diabetes mellitus and prediabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):217.[doi:10.3760/cma.j.issn.1673-4157.2015.04.001]
[7]安丽,王秋月.Visfatin与胰岛素抵抗及糖尿病肾病的发病机制[J].国际内分泌代谢杂志,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
An Li,Wang Qiuyue..Visfatin in the pathogenesis of insulin resistance and diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):248.[doi:10.3760/cma.j.issn.1673-4157.2015.04.009]
[8]冯静,魏亚聪,宋光耀.成纤维细胞生长因子21与胰岛素抵抗[J].国际内分泌代谢杂志,2015,(04):268.[doi:10.3760/cma.j.issn.1673-4157.2015.04.015]
Feng Jing*,Wei Yacong,Song Guangyao..Fibroblast growth factor 21 and insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(04):268.[doi:10.3760/cma.j.issn.1673-4157.2015.04.015]
[9]臧莎莎,朱亚军,宋光耀.Lipin与糖脂代谢[J].国际内分泌代谢杂志,2014,(01):22.[doi:10.3760/cma.j.issn.1673-4157.2014.01.006]
Zang Shasha*,Zhu Yajun,Song Guangyao.Lipin and glucolipid metabolism[J].International Journal of Endocrinology and Metabolism,2014,(04):22.[doi:10.3760/cma.j.issn.1673-4157.2014.01.006]
[10]王登,贾正平,李茂星,等.糖皮质激素与2型糖尿病[J].国际内分泌代谢杂志,2014,(02):118.[doi:10.3760/cma.j.issn.1673-4157.2014.02.014]
Wang Deng*,Jia Zhengping,Li Maoxing,et al.Glucocorticoid and type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(04):118.[doi:10.3760/cma.j.issn.1673-4157.2014.02.014]